Fine-Tuning Mybl2 Is Required for Proper Mesenchymal-to-Epithelial Transition during Somatic Reprogramming
Summary: During somatic reprogramming, Yamanaka’s pioneer factors regulate a complex sequence of molecular events leading to the activation of a network of pluripotency factors, ultimately resulting in the acquisition and maintenance of a pluripotent state. Here, we show that, contrary to the plurip...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-08-01
|
Series: | Cell Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211124718311161 |
id |
doaj-a18ab7e136ff4233bfc83f272e0f8a76 |
---|---|
record_format |
Article |
spelling |
doaj-a18ab7e136ff4233bfc83f272e0f8a762020-11-24T21:21:03ZengElsevierCell Reports2211-12472018-08-0124614961511.e8Fine-Tuning Mybl2 Is Required for Proper Mesenchymal-to-Epithelial Transition during Somatic ReprogrammingCarl Ward0Giacomo Volpe1Pierre Cauchy2Anetta Ptasinska3Ruba Almaghrabi4Daniel Blakemore5Monica Nafria6Doris Kestner7Jon Frampton8George Murphy9Yosef Buganim10Keisuke Kaji11Paloma García12Institute of Cancer and Genomic Science, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UKInstitute of Cancer and Genomic Science, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UKInstitute of Cancer and Genomic Science, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK; Department of Molecular and Cellular Immunology, Max Planck Institute of Immunobiology and Epigenetics, Freiburg, GermanyInstitute of Cancer and Genomic Science, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UKInstitute of Cancer and Genomic Science, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UKInstitute of Cancer and Genomic Science, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UKInstitute of Cancer and Genomic Science, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UKInstitute of Cancer and Genomic Science, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UKInstitute of Cancer and Genomic Science, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UKDepartment of Medicine, Boston University School of Medicine, Boston, MA, USAThe Institute for Medical Research Israel-Canada, The Hebrew University Hadassah Medical School, Jerusalem, IsraelMRC Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, UKInstitute of Cancer and Genomic Science, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK; Corresponding authorSummary: During somatic reprogramming, Yamanaka’s pioneer factors regulate a complex sequence of molecular events leading to the activation of a network of pluripotency factors, ultimately resulting in the acquisition and maintenance of a pluripotent state. Here, we show that, contrary to the pluripotency factors studied so far, overexpression of Mybl2 inhibits somatic reprogramming. Our results demonstrate that Mybl2 levels are crucial to the dynamics of the reprogramming process. Mybl2 overexpression changes chromatin conformation, affecting the accessibility of pioneer factors to the chromatin and promoting accessibility for early immediate response genes known to be reprogramming blockers. These changes in the chromatin landscape ultimately lead to a deregulation of key genes that are important for the mesenchymal-to-epithelial transition. This work defines Mybl2 level as a gatekeeper for the initiation of reprogramming, providing further insights into the tight regulation and required coordination of molecular events that are necessary for changes in cell fate identity during the reprogramming process. : Ward et al. show that Mybl2 expression level is a gatekeeper for the initiation of reprogramming. They find that Mybl2 overexpression leads to changes in the chromatin landscape, affecting the accessibility of pioneer factors to the chromatin and promoting accessibility for the AP1 family of transcription factors, known to be reprogramming blockers. Keywords: somatic reprogramming, mesenchymal-to-epithelial transition, chromatin landscape, ATAC-sequencing, reprogramming blockers, chromatin remodeling, induced pluripotent stem cells, AP1, Sox2, Junhttp://www.sciencedirect.com/science/article/pii/S2211124718311161 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Carl Ward Giacomo Volpe Pierre Cauchy Anetta Ptasinska Ruba Almaghrabi Daniel Blakemore Monica Nafria Doris Kestner Jon Frampton George Murphy Yosef Buganim Keisuke Kaji Paloma García |
spellingShingle |
Carl Ward Giacomo Volpe Pierre Cauchy Anetta Ptasinska Ruba Almaghrabi Daniel Blakemore Monica Nafria Doris Kestner Jon Frampton George Murphy Yosef Buganim Keisuke Kaji Paloma García Fine-Tuning Mybl2 Is Required for Proper Mesenchymal-to-Epithelial Transition during Somatic Reprogramming Cell Reports |
author_facet |
Carl Ward Giacomo Volpe Pierre Cauchy Anetta Ptasinska Ruba Almaghrabi Daniel Blakemore Monica Nafria Doris Kestner Jon Frampton George Murphy Yosef Buganim Keisuke Kaji Paloma García |
author_sort |
Carl Ward |
title |
Fine-Tuning Mybl2 Is Required for Proper Mesenchymal-to-Epithelial Transition during Somatic Reprogramming |
title_short |
Fine-Tuning Mybl2 Is Required for Proper Mesenchymal-to-Epithelial Transition during Somatic Reprogramming |
title_full |
Fine-Tuning Mybl2 Is Required for Proper Mesenchymal-to-Epithelial Transition during Somatic Reprogramming |
title_fullStr |
Fine-Tuning Mybl2 Is Required for Proper Mesenchymal-to-Epithelial Transition during Somatic Reprogramming |
title_full_unstemmed |
Fine-Tuning Mybl2 Is Required for Proper Mesenchymal-to-Epithelial Transition during Somatic Reprogramming |
title_sort |
fine-tuning mybl2 is required for proper mesenchymal-to-epithelial transition during somatic reprogramming |
publisher |
Elsevier |
series |
Cell Reports |
issn |
2211-1247 |
publishDate |
2018-08-01 |
description |
Summary: During somatic reprogramming, Yamanaka’s pioneer factors regulate a complex sequence of molecular events leading to the activation of a network of pluripotency factors, ultimately resulting in the acquisition and maintenance of a pluripotent state. Here, we show that, contrary to the pluripotency factors studied so far, overexpression of Mybl2 inhibits somatic reprogramming. Our results demonstrate that Mybl2 levels are crucial to the dynamics of the reprogramming process. Mybl2 overexpression changes chromatin conformation, affecting the accessibility of pioneer factors to the chromatin and promoting accessibility for early immediate response genes known to be reprogramming blockers. These changes in the chromatin landscape ultimately lead to a deregulation of key genes that are important for the mesenchymal-to-epithelial transition. This work defines Mybl2 level as a gatekeeper for the initiation of reprogramming, providing further insights into the tight regulation and required coordination of molecular events that are necessary for changes in cell fate identity during the reprogramming process. : Ward et al. show that Mybl2 expression level is a gatekeeper for the initiation of reprogramming. They find that Mybl2 overexpression leads to changes in the chromatin landscape, affecting the accessibility of pioneer factors to the chromatin and promoting accessibility for the AP1 family of transcription factors, known to be reprogramming blockers. Keywords: somatic reprogramming, mesenchymal-to-epithelial transition, chromatin landscape, ATAC-sequencing, reprogramming blockers, chromatin remodeling, induced pluripotent stem cells, AP1, Sox2, Jun |
url |
http://www.sciencedirect.com/science/article/pii/S2211124718311161 |
work_keys_str_mv |
AT carlward finetuningmybl2isrequiredforpropermesenchymaltoepithelialtransitionduringsomaticreprogramming AT giacomovolpe finetuningmybl2isrequiredforpropermesenchymaltoepithelialtransitionduringsomaticreprogramming AT pierrecauchy finetuningmybl2isrequiredforpropermesenchymaltoepithelialtransitionduringsomaticreprogramming AT anettaptasinska finetuningmybl2isrequiredforpropermesenchymaltoepithelialtransitionduringsomaticreprogramming AT rubaalmaghrabi finetuningmybl2isrequiredforpropermesenchymaltoepithelialtransitionduringsomaticreprogramming AT danielblakemore finetuningmybl2isrequiredforpropermesenchymaltoepithelialtransitionduringsomaticreprogramming AT monicanafria finetuningmybl2isrequiredforpropermesenchymaltoepithelialtransitionduringsomaticreprogramming AT doriskestner finetuningmybl2isrequiredforpropermesenchymaltoepithelialtransitionduringsomaticreprogramming AT jonframpton finetuningmybl2isrequiredforpropermesenchymaltoepithelialtransitionduringsomaticreprogramming AT georgemurphy finetuningmybl2isrequiredforpropermesenchymaltoepithelialtransitionduringsomaticreprogramming AT yosefbuganim finetuningmybl2isrequiredforpropermesenchymaltoepithelialtransitionduringsomaticreprogramming AT keisukekaji finetuningmybl2isrequiredforpropermesenchymaltoepithelialtransitionduringsomaticreprogramming AT palomagarcia finetuningmybl2isrequiredforpropermesenchymaltoepithelialtransitionduringsomaticreprogramming |
_version_ |
1726001412981129216 |